HEADER LIGASE/LIGASE INHIBITOR 26-MAY-21 7N12 TITLE CRYSTAL STRUCTURE OF THE M. ABSCESSUS LEURS EDITING DOMAIN IN COMPLEX TITLE 2 WITH EPETRABOROLE-AMP ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUCINE--TRNA LIGASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: LEUCYL-TRNA SYNTHETASE,LEURS; COMPND 5 EC: 6.1.1.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTEROIDES ABSCESSUS; SOURCE 3 ORGANISM_TAXID: 36809; SOURCE 4 GENE: LEUS, D2E76_19720; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PMABSED KEYWDS OXABOROLE, INHIBITOR, COMPLEX, ANTIBIOTIC, LIGASE-LIGASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.KALTHOFF,M.SCHMEING REVDAT 3 18-OCT-23 7N12 1 REMARK REVDAT 2 27-OCT-21 7N12 1 JRNL REVDAT 1 06-OCT-21 7N12 0 JRNL AUTH J.R.SULLIVAN,A.LUPIEN,E.KALTHOFF,C.HAMELA,L.TAYLOR, JRNL AUTH 2 K.A.MUNRO,T.M.SCHMEING,L.KREMER,M.A.BEHR JRNL TITL EFFICACY OF EPETRABOROLE AGAINST MYCOBACTERIUM ABSCESSUS IS JRNL TITL 2 INCREASED WITH NORVALINE. JRNL REF PLOS PATHOG. V. 17 09965 2021 JRNL REFN ESSN 1553-7374 JRNL PMID 34637487 JRNL DOI 10.1371/JOURNAL.PPAT.1009965 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 92.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 56594 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 4142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 92.8000 - 5.2800 1.00 2638 134 0.2294 0.2369 REMARK 3 2 5.2800 - 4.1900 1.00 2644 112 0.1706 0.1893 REMARK 3 3 4.1900 - 3.6600 0.99 2647 119 0.1662 0.2329 REMARK 3 4 3.6600 - 3.3300 0.99 2563 149 0.1573 0.1937 REMARK 3 5 3.3300 - 3.0900 1.00 2629 167 0.1723 0.2100 REMARK 3 6 3.0900 - 2.9100 0.99 2662 116 0.1745 0.2191 REMARK 3 7 2.9100 - 2.7600 1.00 2610 153 0.1840 0.2086 REMARK 3 8 2.7600 - 2.6400 1.00 2624 128 0.1748 0.2240 REMARK 3 9 2.6400 - 2.5400 0.99 2659 145 0.1719 0.2298 REMARK 3 10 2.5400 - 2.4500 1.00 2601 141 0.1690 0.1908 REMARK 3 11 2.4500 - 2.3800 1.00 2613 150 0.1768 0.2158 REMARK 3 12 2.3800 - 2.3100 1.00 2609 141 0.1643 0.2221 REMARK 3 13 2.3100 - 2.2500 1.00 2673 148 0.1732 0.2539 REMARK 3 14 2.2500 - 2.1900 1.00 2567 129 0.1745 0.2330 REMARK 3 15 2.1900 - 2.1400 1.00 2645 120 0.1667 0.2073 REMARK 3 16 2.1400 - 2.1000 1.00 2664 144 0.1781 0.2138 REMARK 3 17 2.1000 - 2.0500 1.00 2580 136 0.1781 0.2551 REMARK 3 18 2.0500 - 2.0200 0.99 2676 136 0.1709 0.2060 REMARK 3 19 2.0200 - 1.9800 0.98 2530 159 0.1861 0.2448 REMARK 3 20 1.9800 - 1.9500 0.99 2614 128 0.1835 0.2254 REMARK 3 21 1.9500 - 1.9100 0.99 2671 149 0.2009 0.2404 REMARK 3 22 1.9100 - 1.8900 0.99 2578 141 0.2045 0.2423 REMARK 3 23 1.8900 - 1.8600 0.99 2531 150 0.2183 0.3002 REMARK 3 24 1.8600 - 1.8300 0.99 2686 140 0.2137 0.2611 REMARK 3 25 1.8300 - 1.8100 0.99 2612 137 0.2242 0.2623 REMARK 3 26 1.8100 - 1.7800 0.99 2595 127 0.2335 0.2858 REMARK 3 27 1.7800 - 1.7600 0.99 2564 145 0.2434 0.2960 REMARK 3 28 1.7600 - 1.7400 0.99 2669 159 0.2508 0.2993 REMARK 3 29 1.7400 - 1.7200 0.99 2660 113 0.2780 0.2762 REMARK 3 30 1.7200 - 1.7000 1.00 2575 126 0.2997 0.3319 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.205 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.931 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 2936 REMARK 3 ANGLE : 1.216 4035 REMARK 3 CHIRALITY : 0.069 454 REMARK 3 PLANARITY : 0.009 523 REMARK 3 DIHEDRAL : 21.345 1057 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7N12 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000257108. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08B1-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.52131 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 3.4.3 REMARK 200 DATA SCALING SOFTWARE : DIALS 3.4.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56594 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.520 REMARK 200 RESOLUTION RANGE LOW (A) : 92.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.35 REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.15.2_3472 REMARK 200 STARTING MODEL: 5AGR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 UL 7.5 MG/ML PROTEIN SOLUTION (50 MM REMARK 280 TRIS PH 7.5, 150 MM NACL. 2 MM BME) WAS MIXED WITH REMARK 280 CRYSTALLIZATION SOLUTION (100 MM HEPES, PH 7.5, 2% PEG400, 2.1 M REMARK 280 AMMONIUM SULFATE, 10 MM AMP, 1 MM EPETRABOROLE, 15% GLYCEROL), REMARK 280 PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.71950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.55350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.71950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.55350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 726 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 716 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 303 REMARK 465 ASP B 382 REMARK 465 LEU B 383 REMARK 465 GLU B 384 REMARK 465 ARG B 385 REMARK 465 GLN B 386 REMARK 465 GLU B 387 REMARK 465 ASN B 388 REMARK 465 SER A 303 REMARK 465 ASP A 382 REMARK 465 LEU A 383 REMARK 465 GLU A 384 REMARK 465 ARG A 385 REMARK 465 GLN A 386 REMARK 465 GLU A 387 REMARK 465 ASN A 388 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 304 CG CD OE1 NE2 REMARK 470 GLU B 371 CG CD OE1 OE2 REMARK 470 ARG B 375 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 380 CG CD CE NZ REMARK 470 SER B 381 OG REMARK 470 LYS B 389 CG CD CE NZ REMARK 470 GLU B 390 CG CD OE1 OE2 REMARK 470 LYS B 491 CG CD CE NZ REMARK 470 ARG B 498 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 304 CG CD OE1 NE2 REMARK 470 GLN A 345 CG CD OE1 NE2 REMARK 470 LYS A 380 CG CD CE NZ REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 LYS A 491 CG CD CE NZ REMARK 470 ARG A 498 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE2 HIS A 432 H VAL A 450 1.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 471 -118.25 51.49 REMARK 500 HIS A 432 10.00 -141.19 REMARK 500 ASP A 471 -125.90 53.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 777 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH B 778 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH B 779 DISTANCE = 6.10 ANGSTROMS REMARK 525 HOH B 780 DISTANCE = 7.56 ANGSTROMS REMARK 525 HOH B 781 DISTANCE = 8.67 ANGSTROMS REMARK 525 HOH A 795 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH A 796 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH A 797 DISTANCE = 7.02 ANGSTROMS REMARK 525 HOH A 798 DISTANCE = 7.08 ANGSTROMS REMARK 525 HOH A 799 DISTANCE = 7.65 ANGSTROMS REMARK 525 HOH A 800 DISTANCE = 7.81 ANGSTROMS REMARK 525 HOH A 801 DISTANCE = 8.01 ANGSTROMS REMARK 525 HOH A 802 DISTANCE = 8.40 ANGSTROMS REMARK 525 HOH A 803 DISTANCE = 8.74 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 365 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 365 A 501 DBREF1 7N12 B 303 498 UNP A0A0U0XQP3_9MYCO DBREF2 7N12 B A0A0U0XQP3 303 498 DBREF1 7N12 A 303 498 UNP A0A0U0XQP3_9MYCO DBREF2 7N12 A A0A0U0XQP3 303 498 SEQADV 7N12 ALA B 315 UNP A0A0U0XQP VAL 315 CONFLICT SEQADV 7N12 THR B 355 UNP A0A0U0XQP ALA 355 CONFLICT SEQADV 7N12 ALA A 315 UNP A0A0U0XQP VAL 315 CONFLICT SEQADV 7N12 THR A 355 UNP A0A0U0XQP ALA 355 CONFLICT SEQRES 1 B 196 SER GLN GLY ALA SER VAL LEU PHE GLY ALA PRO GLY ALA SEQRES 2 B 196 GLY ASP ILE GLU VAL PHE THR THR ARG PRO ASP THR LEU SEQRES 3 B 196 PHE GLY ALA THR TYR MET VAL LEU ALA PRO GLU HIS PRO SEQRES 4 B 196 LEU VAL ASP GLN LEU ALA ALA ASP VAL TRP PRO GLN ASP SEQRES 5 B 196 THR ASP PRO ARG TRP THR GLY GLY GLN ASP SER PRO ARG SEQRES 6 B 196 ALA ALA ILE GLU GLN TYR ARG ARG SER ILE ALA ALA LYS SEQRES 7 B 196 SER ASP LEU GLU ARG GLN GLU ASN LYS GLU LYS THR GLY SEQRES 8 B 196 VAL PHE THR GLY ALA TYR ALA THR ASN PRO VAL SER GLY SEQRES 9 B 196 LYS PRO VAL PRO VAL PHE ILE ALA ASP TYR VAL LEU LEU SEQRES 10 B 196 GLY TYR GLY THR GLY ALA ILE MET ALA VAL PRO GLY HIS SEQRES 11 B 196 ASP GLN ARG ASP TRP ASP PHE ALA ASN THR PHE GLY LEU SEQRES 12 B 196 PRO VAL GLN GLU VAL ILE SER GLY GLY ASP VAL THR LYS SEQRES 13 B 196 ALA ALA TYR THR GLY ASP GLY VAL LEU VAL ASN SER ASP SEQRES 14 B 196 TYR LEU ASP GLY LEU ASP ILE GLU ALA ALA LYS VAL GLU SEQRES 15 B 196 VAL THR ARG ARG LEU VAL LYS ASP GLY ARG GLY GLU SER SEQRES 16 B 196 ARG SEQRES 1 A 196 SER GLN GLY ALA SER VAL LEU PHE GLY ALA PRO GLY ALA SEQRES 2 A 196 GLY ASP ILE GLU VAL PHE THR THR ARG PRO ASP THR LEU SEQRES 3 A 196 PHE GLY ALA THR TYR MET VAL LEU ALA PRO GLU HIS PRO SEQRES 4 A 196 LEU VAL ASP GLN LEU ALA ALA ASP VAL TRP PRO GLN ASP SEQRES 5 A 196 THR ASP PRO ARG TRP THR GLY GLY GLN ASP SER PRO ARG SEQRES 6 A 196 ALA ALA ILE GLU GLN TYR ARG ARG SER ILE ALA ALA LYS SEQRES 7 A 196 SER ASP LEU GLU ARG GLN GLU ASN LYS GLU LYS THR GLY SEQRES 8 A 196 VAL PHE THR GLY ALA TYR ALA THR ASN PRO VAL SER GLY SEQRES 9 A 196 LYS PRO VAL PRO VAL PHE ILE ALA ASP TYR VAL LEU LEU SEQRES 10 A 196 GLY TYR GLY THR GLY ALA ILE MET ALA VAL PRO GLY HIS SEQRES 11 A 196 ASP GLN ARG ASP TRP ASP PHE ALA ASN THR PHE GLY LEU SEQRES 12 A 196 PRO VAL GLN GLU VAL ILE SER GLY GLY ASP VAL THR LYS SEQRES 13 A 196 ALA ALA TYR THR GLY ASP GLY VAL LEU VAL ASN SER ASP SEQRES 14 A 196 TYR LEU ASP GLY LEU ASP ILE GLU ALA ALA LYS VAL GLU SEQRES 15 A 196 VAL THR ARG ARG LEU VAL LYS ASP GLY ARG GLY GLU SER SEQRES 16 A 196 ARG HET 365 B 501 63 HET SO4 B 502 5 HET 365 A 501 63 HETNAM 365 [(1S,5R,6R,7'S,8R)-7'-(AMINOMETHYL)-6-(6-AMINOPURIN-9- HETNAM 2 365 YL)-2'-(3-OXIDANYLPROPOXY)SPIRO[2,4,7-TRIOXA-3- HETNAM 3 365 BORANUIDABICYCLO[3.3.0]OCTANE-3,9'-8-OXA-9- HETNAM 4 365 BORANUIDABICYCLO[4.3.0]NONA-1(6),2,4-TRIENE]-8- HETNAM 5 365 YL]METHYL DIHYDROGEN PHOSPHATE HETNAM SO4 SULFATE ION HETSYN 365 3-AMINOMETHYL-7-(3-HYDROXY-PROPOXY)-3H-BENZO[C][1, HETSYN 2 365 2]OXABOROL-1-OL MODIFIED ADENOSINE FORMUL 3 365 2(C21 H27 B N6 O10 P 1-) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *384(H2 O) HELIX 1 AA1 ARG B 324 ALA B 331 5 8 HELIX 2 AA2 LEU B 342 ALA B 347 1 6 HELIX 3 AA3 ASP B 356 THR B 360 5 5 HELIX 4 AA4 SER B 365 ALA B 379 1 15 HELIX 5 AA5 ASP B 433 GLY B 444 1 12 HELIX 6 AA6 SER B 470 ASP B 474 5 5 HELIX 7 AA7 ASP B 477 ASP B 492 1 16 HELIX 8 AA8 ARG A 324 ALA A 331 5 8 HELIX 9 AA9 LEU A 342 ALA A 347 1 6 HELIX 10 AB1 ASP A 356 THR A 360 5 5 HELIX 11 AB2 SER A 365 ALA A 379 1 15 HELIX 12 AB3 ASP A 433 GLY A 444 1 12 HELIX 13 AB4 SER A 470 ASP A 474 5 5 HELIX 14 AB5 ASP A 477 ASP A 492 1 16 SHEET 1 AA1 3 GLY B 316 THR B 322 0 SHEET 2 AA1 3 GLY B 305 ALA B 312 -1 N ALA B 306 O THR B 322 SHEET 3 AA1 3 GLY B 495 ARG B 498 -1 O GLU B 496 N SER B 307 SHEET 1 AA2 4 VAL B 394 THR B 401 0 SHEET 2 AA2 4 PRO B 408 ILE B 413 -1 O VAL B 409 N ALA B 400 SHEET 3 AA2 4 TYR B 333 LEU B 336 1 N MET B 334 O PHE B 412 SHEET 4 AA2 4 ALA B 425 ALA B 428 -1 O ALA B 428 N TYR B 333 SHEET 1 AA3 3 GLY A 316 THR A 322 0 SHEET 2 AA3 3 ALA A 306 ALA A 312 -1 N ALA A 306 O THR A 322 SHEET 3 AA3 3 GLY A 495 SER A 497 -1 O GLU A 496 N SER A 307 SHEET 1 AA4 4 VAL A 394 THR A 401 0 SHEET 2 AA4 4 PRO A 408 ILE A 413 -1 O VAL A 409 N ALA A 400 SHEET 3 AA4 4 TYR A 333 LEU A 336 1 N LEU A 336 O PHE A 412 SHEET 4 AA4 4 ALA A 425 ALA A 428 -1 O ILE A 426 N VAL A 335 SITE 1 AC1 19 PHE B 321 THR B 322 THR B 323 ARG B 324 SITE 2 AC1 19 TYR B 416 VAL B 417 LEU B 418 TYR B 421 SITE 3 AC1 19 ILE B 426 MET B 427 VAL B 429 HIS B 432 SITE 4 AC1 19 ASP B 433 ARG B 435 ASP B 436 HOH B 673 SITE 5 AC1 19 HOH B 685 HOH B 690 HOH B 704 SITE 1 AC2 4 ARG A 375 HOH A 617 TYR B 472 ARG B 488 SITE 1 AC3 19 PHE A 321 THR A 322 THR A 323 ARG A 324 SITE 2 AC3 19 TYR A 416 VAL A 417 LEU A 418 TYR A 421 SITE 3 AC3 19 ILE A 426 MET A 427 VAL A 429 HIS A 432 SITE 4 AC3 19 ASP A 433 ARG A 435 ASP A 436 HOH A 603 SITE 5 AC3 19 HOH A 680 HOH A 685 HOH A 701 CRYST1 113.439 37.107 100.287 90.00 112.28 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008815 0.000000 0.003612 0.00000 SCALE2 0.000000 0.026949 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010776 0.00000